Method: Shotgun metagenomic sequencing (CLIA 21D2062464); not cleared or approved by the FDA. Results reflect relative microbial abundance for wellness education purposes. Not intended to diagnose or treat disease and not a substitute for clinical consultation. Microbial associations are based on emerging scientific research and may change over time.
A derived biomarker is a value that is calculated from other directly measured biomarkers rather than being measured directly in the lab.
Key benefits of Pseudomonas aeruginosa testing
- Multidrug-resistant opportunistic pathogen monitoring
- healthcare-associated and environmental exposure tracking
What is Pseudomonas aeruginosa?
Pseudomonas aeruginosa is a gram-negative opportunistic pathogen known for intrinsic antibiotic resistance and the ability to cause serious infections in immunocompromised individuals. Its detection in the gut microbiome may reflect environmental acquisition or healthcare exposure. Detected by shotgun sequencing.
Why is Pseudomonas aeruginosa important?
P. aeruginosa is among the most clinically challenging opportunistic pathogens due to its broad antibiotic resistance. Gut colonization can serve as a reservoir for potential infection. Detection in a routine gut microbiome test is an atypical finding worth attention.
What insights will I get?
Discuss any detection of P. aeruginosa with your care team, particularly in the context of overall antibiotic resistance burden and recent healthcare exposure.





.avif)
.avif)

